BlueRock Therapeutics is a biotechnology company that develops engineered cell therapies to cure diseases. The company's platform is based on induced pluripotent stem cells (iPSCs) and gene editing technologies. BlueRock Therapeutics is focused on developing therapies for diseases of the central nervous system, cardiovascular system, and immunology. The company was founded in 2016 and is headquartered in Cambridge, Massachusetts.